Long-term results of reirradiation and hyperthermia in recurrent breast cancer
Publish place: 9th International Breast Cancer Congress
Publish Year: 1392
Type: Conference paper
Language: English
View: 442
این Paper فقط به صورت چکیده توسط دبیرخانه ارسال شده است و فایل کامل قابل دریافت نیست. برای یافتن Papers دارای فایل کامل، از بخش [جستجوی مقالات فارسی] اقدام فرمایید.
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- I'm the author of the paper
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
Export:
Document National Code:
ICBCMED09_005
Index date: 18 April 2018
Long-term results of reirradiation and hyperthermia in recurrent breast cancer abstract
Randomized studies have shown that hyperthermia when added to reirradiation results in a higher local tumour control rate. Here we report long-term results of patients treated with reirradiation and hyperthermia in our institute since 1992. Materials and methods. 198 patients with subclinical and 250 with irresectable disease were treated, including 36 patients with tissue transfers. All patients were treated with 8 fractions of 4 Gy twice weekly, and 8 (until 1996) or 4 one-hour hyperthermia treatments applied after radiotherapy. Approximately half of the patients received radiotherapy in another institute. Hyperthermia was applied with custom built Lucite Cone Applicators operating at a frequency of 433 MHz and the whole reirradiation volume was heated. Temperatures were measured on the skin, and interstitially with fiber-optic multisensor probes within closed-tip catheters. Results In subclinical disease the 3- and 5-year local control (LC) was 83% and 78%. In patients with irresectable disease complete response was 70% and 3- and 5-year LC was 40% and 39%. 5- and 10-year overall survival was 60 and 36% for subclinical disease, and 18 and 10% for irresectable disease. Both LC and toxicity in patients with tissue transfers were similar to those in the other patients. Superficially measured temperatures > 43° were associated with more hyperthermia toxicity. The longer time interval between radiation and hyperthermia in patients irradiated elsewhere, compared to the time interval in patients irradiated in the Erasmus MC, did not result in inferior results. Patients with subclinical disease irradiated elsewhere had significantly less late grade 3-4 toxicity (7% at 5 years) than patients irradiated in the Erasmus MC (15%). Conclusions These results again show that reirradiation with hyperthermia is worthwhile. Patients with tissue transfers can be treated safely. Hyperthermia toxicity may be decreased when superficially measured temperatures are kept below 43°C.
Long-term results of reirradiation and hyperthermia in recurrent breast cancer authors
Jacoba van der Zee
Department of Radiation Oncology, Hyperthermia Unit;
Marianne Linthorst
Department of Radiation Oncology, Hyperthermia Unit;
Albert van Geel
Department of Surgical Oncology;
Margreet Baaijens
Department of Radiation Oncology